Investors need to pay close attention to LFVN stock based on the movements in the options market lately.
LifeVantage Corporation (LFVN) Q3 2026 Earnings Call Transcript
Lifevantage (LFVN) came out with quarterly earnings of $0.12 per share, missing the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.26 per share a year ago.
| Food Products Industry | Consumer Staples Sector | Carl A. Aure CEO | XFRA Exchange | 53222K205 CUSIP |
| US Country | 238 Employees | 1 Jun 2026 Last Dividend | 19 Oct 2015 Last Split | 5 Oct 2004 IPO Date |
LifeVantage Corporation, founded in 2003 and based in Lehi, Utah, operates within the health and wellness industry focusing on the identification, research, development, formulation, and sale of advanced nutrigenomic activators and a wide array of other health-related products. These include dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company markets its products globally through a network of independent distributors, reaching multiple countries including the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and the Philippines. Its product offerings are sold primarily through its website, leveraging the direct selling model to foster personal connections between its distributors and customers.